Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF for chagasic cardiomyopathy
RBR-6tnw2bPhase 2Not yet recruiting
- Sponsor
- Fundação Oswaldo Cruz
- Start
- Jan 2014
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of filgrastim in Chagas cardiomyopathy (CCC) and chronic heart failure (CHF), sponsored by Fundação Oswaldo Cruz. Planned start Jan 2014; status: not yet recruiting.
02
Drugs
filgrastim
03
Conditions
Chagas cardiomyopathy (CCC)chronic heart failure (CHF)
Beyond the preview
Go deeper on RBR-6tnw2b.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6tnw2b.